[PDF][PDF] Association between tacrolimus concentration and genetic polymorphisms of CYP3A5 and ABCB1 during the early stage after liver transplant in an Iranian …
M Rahsaz, N Azarpira, S Nikeghbalian… - Exp Clin …, 2012 - academia.edu
Objectives: Tacrolimus is widely used as an immunosuppressive drug in liver transplant
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
[PDF][PDF] Association Between Tacrolimus Concentration and Genetic Polymorphisms of CYP3A5 and ABCB1 During the Early Stage After Liver Transplant in an Iranian …
M Rahsaz, N Azarpira, S Nikeghbalian… - Experimental and …, 2012 - academia.edu
Objectives: Tacrolimus is widely used as an immunosuppressive drug in liver transplant
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
Association between tacrolimus concentration and genetic polymorphisms of CYP3A5 and ABCB1 during the early stage after liver transplant in an Iranian population.
M Rahsaz, N Azarpira, S Nikeghbalian… - … : Official Journal of the …, 2012 - europepmc.org
Objectives Tacrolimus is widely used as an immunosuppressive drug in liver transplant
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
[PDF][PDF] Association Between Tacrolimus Concentration and Genetic Polymorphisms of CYP3A5 and ABCB1 During the Early Stage After Liver Transplant in an Iranian …
M Rahsaz, N Azarpira, S Nikeghbalian… - Experimental and …, 2012 - researchgate.net
Objectives: Tacrolimus is widely used as an immunosuppressive drug in liver transplant
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
Association between tacrolimus concentration and genetic polymorphisms of CYP3A5 and ABCB1 during the early stage after liver transplant in an Iranian population
M Rahsaz, N Azarpira… - … : official journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Objectives Tacrolimus is widely used as an immunosuppressive drug in liver transplant
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
[PDF][PDF] Association Between Tacrolimus Concentration and Genetic Polymorphisms of CYP3A5 and ABCB1 During the Early Stage After Liver Transplant in an Iranian …
M Rahsaz, N Azarpira, S Nikeghbalian… - Experimental and …, 2012 - scholar.archive.org
Objectives: Tacrolimus is widely used as an immunosuppressive drug in liver transplant
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
[PDF][PDF] Association Between Tacrolimus Concentration and Genetic Polymorphisms of CYP3A5 and ABCB1 During the Early Stage After Liver Transplant in an Iranian …
M Rahsaz, N Azarpira, S Nikeghbalian… - Experimental and …, 2012 - researchgate.net
Objectives: Tacrolimus is widely used as an immunosuppressive drug in liver transplant
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …
recipients with a narrow therapeutic range and variable individualized pharmacokinetics …